Dr. Sarah Shuck

The impact of CeDG for vascular complications

Dr. Shuck is an analytical chemist who is interested in exploring the role of reactive electrophiles in the development of diseases in patients with diabetes. Her lab focuses on the role of methylglyoxal-induced DNA damage as a link between diabetes and the development of cancer and kidney disease.

Back to speakers